Article

Rheumatoid Arthritis Quiz: Initiating Methotrexate

Author(s):

Ingrid Torjesen

Methotrexate has been the mainstay treatment for mild to moderate arthritis for many years, and the recent update to the American College of Rheumatology Guidelines on the Management of Rheumatoid Arthritis aims to maximize the use of methotrexate before advancing to a biologic or targeted synthetic disease-modifying antirheumatic drug (DMARD). With this in mind, it is important to be up-to-speed on initiating methotrexate in patients with rheumatoid arthritis. Test your knowledge with this quiz.

Is the following statement true or false?
The American College of Rheumatology Guidelines on the Management of Rheumatoid Arthritis recommend methotrexate monotherapy over hydroxychloroquine or sulfasalazine


Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Related Content
New Administration Options Approved for Bimekizumab for Psoriasis, PsA
October 14th 2024

New Administration Options Approved for Bimekizumab for Psoriasis, PsA

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
Philip J. Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
October 14th 2024

Guselkumab Yields Durable Improvements in Psoriatic Arthritis

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
Omar Khoja, PhD candidate, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
October 13th 2024

Post-COVID-19 Musculoskeletal Pain Often Fulfills Fibromyalgia Criteria

Victoria Johnson
IV Secukinumab Rapidly Improved Clinical Responses in Psoriatic Arthritis | Image Credit: Altoona Center for Clinical Research
October 12th 2024

IV Secukinumab Rapidly Improved Clinical Responses in Psoriatic Arthritis

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.